Editorial: Preventing Developmental Brain Injury—From Animal Models to Clinical Trials

A variety of brain injuries originating from fetal, perinatal, and neonatal periods may cause mortality, and many of the survivors of those injuries suffer from life-long morbidity. It is our task as researchers to prevent and reduce such brain injuries in infants. This is why we Topic Editors chose the theme “Preventing developmental brain injury—from animal models to clinical trials.”

Among those developing brain injuries, neonatal encephalopathy in full-term infants has been the most crucial issue for decades (1). Neonatal encephalopathy refers to newborns with symptoms of acute cerebral dysfunction such as depressed consciousness, abnormal muscle tone, respiratory distress, feeding difficulties, and seizures (2, 3). Hypoxic-ischemic injury is the most common (up to 85% of cases), and ischemic/hemorrhagic stroke is the second most common, etiology and pathophysiology of neonatal encephalopathy (3). Approximately 3% of babies born in the world die by 4 weeks of age, and asphyxia, i.e., neonatal encephalopathy accounts for 23% of neonatal mortality (4); hence, the mortality rate due to neonatal encephalopathy is estimated to be 70/1,000 livebirths. Almost all (99%) neonatal mortality occurs in resource-limited countries (4). The incidence of neonatal encephalopathy in term newborns has been declining in resource-rich countries, and is currently 1/1,000 livebirths or less (5, 6). Nevertheless, nearly half of infants with neonatal encephalopathy in resource-rich countries die or develop permanent neurological disabilities, such as cerebral palsy, intellectual disability, and epilepsy (7). Therefore, the burden of neonatal encephalopathy remains high for patients, caregivers, and society.

Currently, the most common brain injuries caused during fetal, perinatal, and neonatal periods are those associated with prematurity, i.e., fetal growth restriction, preterm birth, and low birth weight (8). Approximately 15 million newborns were estimated to be born preterm (<37 weeks of gestation) in 2010, which accounted for 11% of all livebirths worldwide, ranging from 5% in some European countries to 18% in some African countries (9). The preterm birth rate has been increasing over the past two decades (9). Similarly, the rate of low birth weight (birth weight is <2,500 g) has been increasing: 7–9% of all live births in resource-rich countries (10, 11) and 11–12% in resource-limited countries (12). Intrauterine hypoperfusion and inflammation are the two leading causes of brain injuries associated with prematurity (13–16). Although most infants do not present obvious neurological symptoms during the neonatal period, they may develop cerebral palsy and neurodevelopmental disorders such as attention-deficit/hyperactive disorders and autistic spectrum disorders during childhood (17, 18). Survivors of very low birth weight (<1,500 g) may present cerebral palsy in 5–10% of the individuals and cognitive/behavioral/attentional deficits in ~50% of these individuals (19, 20). The main focus of outcome studies in neonatal care has been the extremely low-birth-weight (<1,000 g) infants and extremely preterm infants [born before 28 weeks of gestation (9)]. Recent studies, however, have shown that even infants born with mild prematurity (birth weight is 1,500– <2,500 g; gestational age is 32– <37 weeks) have significantly higher risks of developing numerous neurological, psychological, and general health problems later in life (21). This phenomenon is now widely known as DOHaD (developmental origin of health and diseases) (22). While many preclinical studies have been conducted in neonatal encephalopathy, a limited number of preclinical studies have been conducted regarding brain injuries associated with prematurity.

Neonatal encephalopathy and brain injury associated with prematurity seem to be contrasting problems, as the former is a medical emergency during the neonatal period, while the latter is a gradually emerging problem in childhood. While it is important to shed light on rare brain injuries, neonatal encephalopathy in term infants and brain injuries associated with prematurity are the most prominent issues that researchers and funding sources need to address considering their impact on patients and society.

This Research Topic collects 29 articles: 20 animal studies (including 1 in vitro study), 3 clinical studies, 1 combined study with clinical and animal studies, and 5 reviews. Of the 21 animal studies, the majority used rodents, and 3 studies used large animals, i.e., piglets or lambs. Hypoxic-ischemic injury was the most frequently used model (11 articles) in this Research Topic collection. Other models included intrauterine ischemia/inflammation (3 articles) and irradiation (2 articles). As the theme of this Research Topic was “preventing developing brain injury,” many of the animal studies explored the effects of novel therapies. Five studies examined the effects of cell-based therapies, 2 studies examined erythropoietin, and others examined melatonin, inhaled carbon dioxide therapy, and protective ventilation strategies. Some studies examined the effects of certain genomic modifications as possible targets of novel therapies. Clinical studies investigated EEG and blood pressure, IL-10 gene polymorphism, and cerebral lactate in infants with brain damage. Despite the Topic Editors' expectations, there was no manuscript submission of an interventional clinical trial, which may suggest a scarcity of clinical trials and difficulty in conducting clinical trials of novel therapies in sick infants. The review articles summarized the effects of therapies, such as oxytocin, magnesium, and nitric oxide synthase inhibition.

With respect to the demographics of this Research Topic collection, the corresponding author's laboratories are located in a variety of countries: Japan (6 articles), the United States (5 articles), France (4 articles), the United Kingdom (3 articles), Sweden (3 articles), the Netherlands (2 articles), Switzerland (1 article), Germany (1 article), China (1 article), South Korea (1 article), Canada (1 article), and Australia (1 article). Thirteen articles represent international collaborative studies.

The Topic Editors are pleased to have a wide variety of 29 articles from many countries around the world. None of the articles in this collection, however, are from the resource-limited world. It is important to encourage research in this area in resource-limited countries where developmental brain injuries are expected to be most prevalent. We hope that research on neonatal brain injuries will become even more active and will contribute to better preventions and treatments for these injuries in the near future.

Statements

Summary

Keywords

neonatal encephalopathy, brain injury, prematurity and low birth weight, animal model, clinical study

Citation

Tsuji M, Sizonenko SV and Baud O (2019) Editorial: Preventing Developmental Brain Injury—From Animal Models to Clinical Trials. Front. Neurol. 10:775. doi: 10.3389/fneur.2019.00775

Received

20 April 2019

Accepted

03 July 2019

Published

19 July 2019

Volume

10 - 2019

Edited by

Jo Madeleine Wilmshurst, University of Cape Town, South Africa

Reviewed by

Mary Ann Rutherford, King's College London, United Kingdom; Richard Joseph Burman, University of Oxford, United Kingdom

Updates

Check for updates

Copyright

© 2019 Tsuji, Sizonenko and Baud.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Stéphane V. Sizonenko Stephane.Sizonenko@unige.ch

This article was submitted to Pediatric Neurology, a section of the journal Frontiers in Neurology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.